Semaglutide denied due to quantity / dose limits by Anthem?

Anthem's specific coverage criteria for semaglutide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Anthem Limits Semaglutide Quantities — and Why You Can Appeal

Anthem's quantity-limit restrictions on semaglutide are among the most common reasons members find their prescription only partially covered or their refill denied before they expect it. Quantity limits are a cost-management tool, but they are not the end of the road — they are appealable, and many members succeed when they document their clinical need carefully.

## Why This Denial Happens

Anthem sets quantity limits based on its internal medical policy and the FDA-approved dosing schedule for semaglutide. If your prescription exceeds the allowed supply per fill, or if the titration schedule your prescriber wrote does not match the plan's assumptions, the claim will reject at the pharmacy. This does not mean the therapy is wrong for you — it means the paperwork needs to catch up with your clinical picture.

## Your Federal Appeal Rights

You have layered federal protections:

• Internal appeal: You must typically file within 180 days of the denial notice. Anthem is required to decide urgent (expedited) appeals within 72 hours and standard appeals within 30–60 days depending on plan type.
• External review (ACA §2719): If Anthem upholds the denial internally, you may request independent external review within approximately 4 months of the final internal denial. An accredited Independent Review Organization — not Anthem — makes a binding decision.
• ERISA §503 (employer plans): If your coverage is through an employer self-funded plan, ERISA's full-and-fair review standard applies, and you may ultimately pursue federal court review if external review is unavailable.
• Expedited option: If your condition is urgent, request an expedited internal appeal and simultaneous expedited external review — decisions can come within days.

## Documentation to Gather

1. Diagnosis confirmation: Chart notes and any relevant diagnostic workup confirming the condition semaglutide is being prescribed for. 2. Prescribing rationale: A detailed medical-necessity letter from your prescriber explaining why the quantity prescribed is clinically appropriate, referencing the FDA-approved prescribing information and the applicable guideline organization (such as the ADA for diabetes or applicable obesity-medicine guidelines) without asserting specific numbers — your prescriber should tie the dose to your documented clinical status. 3. Titration schedule: Documentation that the quantity requested aligns with the titration schedule in the FDA-approved label. Pull the current FDA prescribing information directly from DailyMed (dailymed.nlm.nih.gov) and have your prescriber confirm the requested quantity matches it. 4. Prior fill history: Pharmacy records showing how you have tolerated and used the medication to date.

## Criteria-Mapping Structure

Copy every quantity-limit requirement from Anthem's published coverage/medical policy for semaglutide (request the policy number from Anthem's member services or find it on their provider portal). For each criterion, write the exact matching fact from your chart:

| Policy Requirement | Your Chart Evidence | |---|---| | [Paste criterion from Anthem policy] | [Exact chart fact, date, provider name] | | [Paste quantity threshold language] | [Prescriber's written justification referencing FDA label] |

Submit the completed table with your prescriber's letter and all supporting records as a single organized packet. Label each exhibit and reference it in a cover letter that opens by stating the specific denial reason and closes by requesting reversal.